Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Citizen Petition On Phenylephrine Requests Pulling OTC Status For Children

This article was originally published in The Tan Sheet

Executive Summary

A citizen petition asks FDA to withdraw OTC approval for phenylephrine use by children under 12 years old and to raise the maximum dose to 25 mg, but also recommends more research to determine the most effective dosage level

Related Content

Petition Answers FDA Questions On Oral Phenylephrine Efficacy, Suggests Removal From Monograph
Congested OTC Monograph Process Can Leave Manufacturers Confused
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
Infant Cold Products Pulled; Waxman Looks For More OTC Risks
Monograph System Challenges Underscored By Pediatric Cold Debate
U.K. Proposes Prescription-Only Status For Pseudoephedrine Products
From Availability To Awareness: 2007 Brings Wide Range Of Goals For CHPA
Phenylephrine “Not Significantly Different From” Placebo – Schering Study
Phenylephrine “Not Significantly Different From” Placebo – Schering Study
Pseudoephedrine Will Be Behind The Counter Across The Country By October





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts